From: Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland
Prescribers (%)
Pharmacists (%)
Therapeutic equivalence
40
60
Quality
35
19
Safety
17
12
Cost savings
4
7
Availability
3